On October 16, data from the Qichacha APP indicated that Aifezhi Pharmaceuticals (Beijing) Technology Co., Ltd. has recently undergone significant industrial and commercial updates. Notably, Shanghai Qishan Investment Co., Ltd., a company affiliated with Tencent, has been added as a shareholder. Concurrently, the firm's registered capital has been elevated to 12 million yuan. According to reports, Aifezhi Pharmaceuticals specializes in AI-driven drug discovery and development.
